Geoff Oxnard

Geoff Oxnard

Chief Tech/Sci/R&D Officer at BLOSSOMHILL THERAPEUTICS, INC.

Net worth: 277 446 $ as of 2026-07-30

49 year
Health Technology
Consumer Services

Profile

Dr. Geoff Oxnard, MD, is a Chief Medical Officer & Executive Vice President at Blossomhill Therapeutics, Inc. Dr. Oxnard was previously employed as a Vice President & Global Head-Thoracic Cancers by Eli Lilly & Co. and a Senior Vice President & Head-Clinical Development by F.
Hoffmann-La Roche Ltd. He received his undergraduate degree from Harvard University and a doctorate degree from Pritzker School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-08-05 17,785 ( 0.06% ) 277 446 $ 2026-07-30

Geoff Oxnard active positions

CompaniesPositionStart
BLOSSOMHILL THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 2024-12-31

Former positions of Geoff Oxnard

CompaniesPositionEnd
ELI LILLY AND COMPANY Corporate Officer/Principal 2024-12-31
Corporate Officer/Principal 2023-08-31
See the detail of Geoff Oxnard's experience

Training of Geoff Oxnard

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

34

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology